UPDATE: McNicoll Lewis Vlak Initiates Galena Biopharma at Buy on Cancer Vaccine Potential
McNicoll Lewis Vlak Maintains Buy on Spectrum Pharmaceuticals After Positive Zevalin Reports
UPDATE: McNicoll Lewis Vlak Initiates Galena Biopharma at Buy on Cancer Vaccine Potential
McNicoll Lewis Vlak Maintains Buy on Spectrum Pharmaceuticals After Positive Zevalin Reports
McNicoll Lewis & Vlak Initiates Avanir Pharmaceuticals at Buy
McNicoll Lewis Vlak Lowers PT on AMAG Pharmaceuticals to $21
Mcnicoll Lewis Vlak Recent News
McNicoll Lewis & Vlak Initiates DexCom at Buy
McNicoll Lewis & Vlak Downgrades BioSante Pharma to Hold
McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23
McNicoll Lewis & Vlak Reiterates Buy, $10 Target on Synta Pharmaceuticals
McNicoll, Lewis & Vlak Maintains Buy Rating and $21 PT on Transcept Pharmaceuticals
McNicoll Lewis & Vlak Maintains Buy Rating and $15 PT on Alnylam Pharmaceuticals
McNicoll Lewis & Vlak Maintains Buy Rating and $10 PT on Synta Pharmaceuticals
UPDATE: McNicoll Lewis & Vlak Lowers PT to $4 on TranS1
McNicoll, Lewis & Vlak Maintains Buy Rating and $8 PT on BioSante Pharmaceuticals
McNicoll, Lewis & Vlak Maintains Buy Rating and $30 PT on Ligand Pharmaceuticals
McNicoll, Lewis & Vlak Maintains Buy, PT of $35 for Genomic Health
McNicoll Lewis & Vlak Maintains Buy on Astex Pharmaceuticals After 3Q EPS Beat
McNicoll Lewis & Vlak Maintains Buy Rating and $30 PT on Ligand Pharmaceuticals
McNicoll Lewis & Vlak Reiterates Buy Rating on Inhibitex Following Positive Study Data
McNicoll Lewis & Vlak Maintains Buy Rating and $15 PT on Alnylam Pharmaceuticals
McNicoll Lewis & Vlak Upgrades Transcept Pharmaceuticals to Buy, $21 PT
McNicoll, Lewis & Vlak Raises PT on Spectranetics to $13, Maintains Buy
McNicoll, Lewis & Vlak Comments On AMAG's Merger with Allos Therapeutics
UPDATE: MLV Initiates Coverage of Prana Biotechnology
McNicoll Lewis & Vlak Initiates Prana Biotechnology at Buy, $6 PT
McNicoll Lewis Vlak Raises PT on Transcept Pharmaceuticals to $8
McNicoll, Lewis & Vlak Initiates Curis at Buy, $8.50 PT
MLV Comments On New H5N1 Bird Flu Vaccine